Sutro Biopharma, Inc. (STRO)
$11.01-17.09%Close
SELLCRISIS · day 44
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $107M
- Beta
- 1.50
- P/E (TTM)
- -0.63
- Short % float
- 27.05%
- Days to cover
- 6.5
- SI change
- -11.0%
- 1W
- -23.81%
- 1M
- -34.89%
- vs SPY 1W
- -24.23%
- vs SPY 1M
- -36.95%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on STRO?
- LOPJLB’s latest quantitative signal on Sutro Biopharma, Inc. (STRO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is STRO in?
- Sutro Biopharma, Inc. (STRO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Sutro Biopharma, Inc. (STRO) do?
- Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free…